NCT03264404 2026-01-27Azacitidine and Pembrolizumab in Pancreatic CancerColumbia UniversityPhase 2 Completed36 enrolled 11 charts
NCT01845805 2022-10-04Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Completed49 enrolled 10 charts